Ezza Aslam Khan, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 121 State Route 31 Ste 300, Flemington, NJ 08822 Phone: 908-788-6474 Fax: 908-788-6616 |
Dr. Sohail G Haddad, M.D Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 121 State Route 31 Ste 300, Flemington, NJ 08822 Phone: 908-788-6474 Fax: 908-788-6616 |
Amna Yaqub, MB,BS Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 121 State Route 31 Ste 300, Flemington, NJ 08822 Phone: 908-788-6474 Fax: 907-788-6616 |
Dr. Joseph Louis Gugliotta, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 121 State Route 31 Ste 300, Flemington, NJ 08822 Phone: 908-788-6474 Fax: 908-788-6616 |
News Archive
Brazilian textile companies have begun producing and marketing fabrics treated with silver and silica nanoparticles developed by the research groups at the Centre for Functional Materials (CDMF) and the Theoretical and Computational Chemistry Laboratory (QTC) at the Universitat Jaume I, in collaboration with the company Nanox Tecnologia, which provide the new fabrics with antibacterial, antifungal and antiviral properties with 99.99% effectiveness.
Fluidigm Corporation has announced a collaboration with BD Biosciences, a segment of BD (Becton, Dickinson and Company), to co-host a public seminar series on the isolation and analysis of single cells. Entitled 'A Powerful Technique for Single-Cell Analysis', the public seminar series will showcase cell isolation using the BD FACSAria™ III Cell Sorter and analysis using the Fluidigm BioMark™ HD System.
Proteins belonging to the large and important family of ABC transporters have been associated with metabolic diseases and can cause resistance to antibiotics. Biochemists from the University of Zurich and the NCCR Structural Biology have succeeded in determining the atomic structure of a new ABC transporter. The insights gained could give rise to new therapies to treat multi-resistant bacteria, cystic fibrosis or gout, for instance.
Researchers suggest that taking nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin or ibuprofen may improve men's urinary health.
Sunshine Biopharma Inc. is pleased to announce that it has recently received notification that the United States Patent and Trademark Office has issued a "Notice of Allowance" for the patent application covering its lead anti-tumor compound, Adva-27a. The allowed claims protect Adva-27a and extensively cover various formulations, derivatives and cancer applications.
› Verified 6 days ago